A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
about
Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.Effectiveness of smoking cessation therapies: a systematic review and meta-analysisSmoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 centurySmoking cessation interventions for smokers with current or past depressionAntidepressants for smoking cessationNicotine replacement therapy for smoking cessationInterventions for preventing weight gain after smoking cessationInterventions for preventing weight gain after smoking cessationNicotine replacement therapy for smoking cessationAntidepressants for smoking cessationAntidepressants for smoking cessationNicotine replacement therapy for smoking cessationEffectiveness of interventions to help people stop smoking: findings from the Cochrane Library.15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XLMotivating and helping smokers to stop smokingAlcohol, nicotine, caffeine, and mental disordersGabapentin for smoking cessationMetabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotineDepression and smoking cessation: does the evidence support psychiatric practice?General Practitioners' views on the provision of nicotine replacement therapy and bupropionUpdating a systematic review--what difference did it make? Case study of nicotine replacement therapyGeneralized seizure in a Mauritian woman taking bupropionPerceptions of substance use, treatment options and training needs among Iranian primary care physiciansNon-pharmacological treatments for COPDCritical limb ischemia: advanced medical therapyMechanistic insights into nicotine withdrawal.Preventive health measures in inflammatory bowel diseaseTobacco addiction and the dysregulation of brain stress systems.Pharmacological interventions for peripheral artery diseaseA fatal case of bupropion (Zyban) hepatotoxicity with autoimmune features: Case report2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuCardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysisBupropion for smokers. Bupropion may not be as good as editorial impliesNewly available treatments for nicotine addiction. Smokers wanting help with stopping now have effective treatment optionsSmoking cessation: integrating recent advances into clinical practiceRacial differences in eligibility and enrollment in a smoking cessation clinical trialReadiness to quit as a predictor for outcomes of smoking-reduction programme with transdermal nicotine patch or bupropion in a sample of 308 patients with schizophrenia.A Prospective, Randomized Trial in the Emergency Department of Suggestive Audio-Therapy under Deep Sedation for Smoking Cessation.Combination treatment for nicotine dependence: state of the science.Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?
P2860
Q21093272-B14A481F-6E97-4881-BE56-C2E28060BDEAQ21093304-984D1FEC-2E52-4003-9AE0-88BBA72253C4Q22305613-249A2326-9DED-4EE9-AEAB-40C52A124915Q24200330-2928F4E8-1CC5-4D6F-BDD5-FF0AD7344D3EQ24201167-A5BADAFF-38B3-4EA2-BA3B-FA7A221D5CC2Q24202991-F6CB05B2-E9AE-40ED-ADD0-4B8CDE9B4A68Q24203883-7D3257A3-7E76-4302-903E-9EF97F8C433DQ24241751-3E0A8743-0448-4864-A03F-25ED41E1845EQ24242851-2C8BCC22-F162-4D9F-9033-70AA2922205DQ24245969-FCD540DD-91B3-4A6C-8450-7B3166E77DBEQ24246426-AB551222-9EAD-49F8-9E93-AA22300570A1Q24246615-1A905994-7E23-4754-9319-415E7C46BCF5Q24524788-5E4C04B2-E13E-4DC2-92CD-5766CE9F2D33Q24530904-68E27ABB-BE0E-49D2-8641-1F02007538C4Q24550593-E8DCCBF9-3AA4-46F1-85A5-AA0BFF03F48EQ24635635-E7C871A9-5ECE-4C0A-BEEB-2BB601549683Q24645235-FD779D61-0229-422E-906D-589FED66CC7FQ24655916-C1BB2D8D-CB1B-4FF9-8C97-8213D2A7B245Q24658121-A8C26C6B-A051-4FD2-B576-B3661D32EE0FQ24794034-E90F64EF-7C1C-4436-9E7A-9395D2F86CC3Q24795974-AB40E670-C739-47A1-BF8C-1CD98FB8F2EAQ24802279-B7AFCC18-FF96-40DB-98E9-037536920903Q24814338-A4365F28-06A2-4A73-89B8-7EEEEFFBE147Q26751407-9AB89CB0-DE22-4939-BAC4-FA3BF4DFD5CCQ26995245-C24B6C99-70D8-4D8D-8242-1906D39EC54FQ27687645-6D014075-F2EC-4840-8C5D-229A048A9E68Q28078112-21613938-E2E9-45CD-86E0-28D7442B7854Q28111988-0D6EC45F-3006-477A-B669-07811ECEFFD5Q28218976-00173870-8BF7-4818-8A86-08B0E63F1203Q28221763-A8EAA08E-1D68-43E2-B987-61862B86498BQ28249469-F2AA87C2-CCED-4E3D-83DA-3A8283B9BA7EQ28303682-460C7113-875A-4993-8AEE-7B4163FBCA79Q28348852-2DFA21B7-62AC-4EC1-954B-9549EF0B90E4Q28364380-3488A68C-523D-4A59-A698-4C01980FC727Q28367163-44C0155C-5DE0-4781-8933-016E287D8462Q28386905-7B266D54-AEB3-411E-92C9-F446DD7511FFQ30209416-66871C78-C029-4856-A253-9E868B44AE24Q30378475-54677BF9-E39C-4FE0-B679-4DA380CC275BQ30436150-FD982166-A07D-453E-AA5F-C6FF3836FC2FQ30442979-30FAF625-8C20-4B6D-9AC1-6E1BE95FA83A
P2860
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
A controlled trial of sustaine ...... or both for smoking cessation.
@en
A controlled trial of sustaine ...... or both for smoking cessation.
@nl
type
label
A controlled trial of sustaine ...... or both for smoking cessation.
@en
A controlled trial of sustaine ...... or both for smoking cessation.
@nl
prefLabel
A controlled trial of sustaine ...... or both for smoking cessation.
@en
A controlled trial of sustaine ...... or both for smoking cessation.
@nl
P2093
P1476
A controlled trial of sustaine ...... or both for smoking cessation.
@en
P2093
Daughton DM
Johnston JA
Jorenby DE
Leischow SJ
Muramoto ML
P304
P356
10.1056/NEJM199903043400903
P407
P577
1999-03-01T00:00:00Z